Demographics, Innovative Outputs and Alliance Strategies of Canadian Biotech Firms

Yael M. Levitte and Sharmistha Bagchi-Sen

European Planning Studies, 2009, vol. 18, issue 5, 669-690

Abstract: This paper focuses on the characteristics of biotech firms that consider alliances as critical to the innovation and commercialization of biotech-based products. First, we consider alliances with both universities and industries. Next, we examine attributes for those firms who consider proximity to universities as critical compared with others that do not put high value on physical proximity. Our study is informed by the literature on the biotechnology industry as well as studies on absorptive capacity, alliances and clusters in exploration and exploitation of knowledge, research and technologies. We analyse data based on a 2002 survey of Canadian biotech firms and find that while collaborative arrangements with universities are the most common among our sample firms, those who assign a high value to such linkages are not necessarily always the biotech firms experiencing commercial success.

Date: 2009
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1080/09654311003593986 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:eurpls:v:18:y:2009:i:5:p:669-690

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/CEPS20

DOI: 10.1080/09654311003593986

Access Statistics for this article

European Planning Studies is currently edited by Philip Cooke and Louis Albrechts

More articles in European Planning Studies from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().